DuPont

DuPont in $1 billion lawsuit over hyped-up GMO technology with 'disappointing results'


Most Viewed Articles
Popular on Facebook
BACK INTO THE CLOSET: Why U.S. reporters are not allowed to write about rainbow events in nations where being gay is still condemned
Depopulation test run? 75% of children who received vaccines in Mexican town now dead or hospitalized
INVESTIGATION: Three days before Dr. Bradstreet was found dead in a river, U.S. govt. agents raided his research facility to seize a breakthrough cancer treatment called GcMAF
A family destroyed: Six-month-old dies after clinic injects baby with 13 vaccines at once without mother's informed consent
Biologist explains how marijuana causes tumor cells to commit suicide
BOMBSHELL: China and America already at war: Tianjin explosion carried out by Pentagon space weapon in retaliation for Yuan currency devaluation... Military helicopters now patrolling Beijing
Companies begin planting microchips under employees' skin
BAM! Chipotle goes 100% non-GMO; flatly rejecting the biotech industry and its toxic food ingredients
ECONOMIC SLAVERY FOR ALL: While we were distracted with the Confederate flag flap, Congress quietly forfeited our entire economic future via fast-track trade authority
NJ cops bust teenagers shoveling snow without a permit
McDonald's in global profit free fall as people everywhere increasingly reject chemically-altered toxic fast food
March Against Monsanto explodes globally... World citizens stage massive protests across 38 countries, 428 cities... mainstream media pretends it never happened
Italian court rules mercury and aluminum in vaccines cause autism: US media continues total blackout of medical truth
SCOTUS same-sex marriage decision may have just legalized the concealed carry of loaded firearms across all 50 states, nullifying gun laws everywhere
Orthorexia Nervosa - New mental disorder aimed at people who insist on eating a clean diet
Vicious attack on Dr. Oz actually waged by biotech mafia; plot to destroy Oz launched after episode on glyphosate toxicity went viral
Nearly every mass shooting in the last 20 years shares one surprising thing? and it's not guns
Holistic cancer treatment pioneer Dr. Nicholas Gonzalez dies suddenly; patients mourn the loss of a compassionate, innovative doctor who helped thousands heal from cancer
Delicious
(NaturalNews) DuPont, the maker of the Pioneer brand of genetically modified corn, has been sued by an investment fund over claims that company managers promoted herbicide-resistant crop traits that they were aware did not work.

The suit was filed by the Ironworkers District Council of Philadelphia and Vicinity Retirement and Pension Plan. The plaintiffs contend that both past and present directors at DuPont wasted corporate assets while fraudulently promoting a specific gene trait known as GAT. The suit was filed in Delaware Chancery Court, Bloomberg News reported.

Prior to filing the suit, lawyers for the plaintiffs issued a legally defined "demand" on Wilmington, Delaware-based DuPont's board "to investigate and commence an action" against executives and directors, according to court papers.

In response to questions from Bloomberg News about the suit, DuPont spokesman Dan Turner said that "several months ago, DuPont's Board of Directors unanimously rejected the shareholder derivative claims" after reviewing the findings of an independent investigation by former Delaware Chancellor William Chandler, as well as two independent DuPont directors. Turner noted that the claims made then "were not supported by the facts or the law and that pursuing those claims would not be in the best interest of DuPont."

Whose GMO seed is better?

The gene trait in question, GAT, came from DuPont's attempts to develop products that allegedly increase crop yields, including the genetic engineering of seeds to make plants more resistant to herbicides aimed at killing weeds instead of crops.

As Bloomberg News reported:

According to court papers, DuPont in 2002 took licenses from Monsanto Co. to use its Roundup Ready trait, which helps crops resist otherwise harmful effects of Monsanto's Roundup herbicide. By 2005, DuPont decided to develop its own trait -- GAT.

"With great fanfare," DuPont announced to the world in 2006 that it would begin selling the GAT (glyphosate acetolactate synthase tolerance) gene trait three years later, in 2009. The company anticipated initial sales of about $200 million a year, the court complaint says. GAT seeds are supposed to be genetically altered to tolerate the class of weed killers known as ALS herbicides.

But soon, "field trials of GAT were producing disappointing results," said the investment fund, but DuPont "continued to publicly hype GAT" and "conceal the failure."

In 2009, the biotech giant revealed that it would add one of Monsanto's genetic technologies used to make crops resistant to its herbicide, because the combination appeared to boost crop yields. But Monsanto, eager to protect its own GMO seeds, sued DuPont; a federal jury in St. Louis awarded Monsanto $1 billion in damages in August 2012.

'Not an objective analysis of the record'

According to the fund lawsuit, as a result of wasteful mismanagement, "the company was sanctioned by a federal judge and millions of dollars were spent on attorneys' fees and other expenses," as directors "failed to institute and maintain adequate controls" which then damaged the company.

Following the judgment, DuPont appointed an "evaluation committee" to look into claims that were being made by shareholders, Bloomberg News said, adding that the DuPont board retained the authority to take any action. The committee summarily issued a report in late November, then provided it to the fund's attorney.

"The report is not an objective analysis of the record and relevant evidence," the fund said. It doesn't "provide an objective and reasoned analysis on which the board could reasonably rely."

The Ironworkers are accusing DuPont of civil fraud and negligent and intentional misrepresentation, as well as waste of corporate assets and breach of fiduciary duties.

Defendants include Ellen Kullman, DuPont's chief executive officer; and directors Eleuthere I. du Pont and Lamberto Andreotti, who is also CEO of Bristol-Myers Squibb, Bloomberg reported.

Visit GMOs.NaturalNews.com for more information and breaking news on this topic.

Sources:

http://www.bloomberg.com

http://www.naturalnews.com

http://phys.org

http://science.naturalnews.com

Follow real-time breaking news headlines on
GMO technology at FETCH.news
Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...

GET SHOW DETAILS
+ a FREE GIFT

Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.